October 16, 2017 8:10 PM ET

Pharmaceuticals

Company Overview of Cingulate Therapeutics LLC

Key Executives for Cingulate Therapeutics LLC

NameBoard RelationshipsTitleAge
Shane J. Schaffer PharmDNo RelationshipsChairman & CEO--
Louis G. Van Horn No RelationshipsChief Financial Officer58

Cingulate Therapeutics LLC Board Members*

NameBoard RelationshipsPrimary CompanyAge
Shane J. Schaffer PharmDNo RelationshipsCingulate Therapeutics LLC--
View All Board Members

Cingulate Therapeutics LLC Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
383.7K
Bonus
408.1K
Total Short Term Compensation
532.7K
Total Value of Options
8.0M
Compensation as of Fiscal Year
Cingulate Therapeutics LLC CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

SciClone Pharmaceuticals, Inc. Announces Board Changes
October 13, 2017 9:31 PM ET
Ocular Therapeutix, Inc. Announces Resignation of James Fortune as Chief Operating Officer, Effective December 31, 2017
October 13, 2017 8:45 PM ET
Suven Life Sciences Limited Announces the Demise K.V. Raghavan as Independent, Non-Executive Director
October 13, 2017 8:08 AM ET
Albert David Limited Announces the Cessation of Karunamay Lahiri as Non- Executive Independent Director of the Company
October 13, 2017 5:52 AM ET
Probiotec Limited Announces Resignation of Graham Morton as Non-Executive Director
October 12, 2017 10:06 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Cingulate Therapeutics LLC, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.